Teva fined $70 million for anti-competitive practices
Business Insurance - Nov 27, 2020
The European Commission has fined Israel-based Teva Pharmaceutical Industries Ltd. and its American subsidiary more than €60 million ($71 million) for anti-competitive practices....
Recommended Articles
Posted: Aug 22, 2023
South Korean insurers’ combined net profits increased to around 8 trillion South Korean won ($5.95 b...
Posted: Aug 22, 2023
According to a new report from Aon PLC, South Africa’s insurance market is continuing to see reduced...
Posted: Aug 22, 2023
Independent insurance brokerage Latin RE is the first Brazilian broker to get a license to operate d...